The absence of cytotoxic effector cells, such as CD8+ T cells or Natural Killer (NK) cells, within tumors establishes an immune-cold tumor microenvironment (TME), contributing to poor immunotherapy responses, as observed in ovarian cancer. This evidence concerns the gene CD8A and ovarian cancer.